test the hypothesis that preprandial HIIP plus insulin glargine is noninferior to preprandial injectable insulin (regular human insulin or insulin lispro) plus insulin glargine with respect to HbA1c 12 weeks per therapy [clinicaltrials_resource:9413a3b5b9f427c08dc62172edf5d7fd]
Administer subcutaneous regular human insulin 30 to 60 minutes before meals, or administer insulin lispro within 15 minutes before meals.
Inject into abdomen only.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
test the hypothesis that preprandial HIIP plus insulin glargine is noninferior to preprandial injectable insulin (regular human insulin or insulin lispro) plus insulin glargine with respect to HbA1c 12 weeks per therapy [clinicaltrials_resource:9413a3b5b9f427c08dc62172edf5d7fd]
Administer subcutaneous regular human insulin 30 to 60 minutes before meals, or administer insulin lispro within 15 minutes before meals.
Inject into abdomen only.
Bio2RDF identifier
9413a3b5b9f427c08dc62172edf5d7fd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9413a3b5b9f427c08dc62172edf5d7fd
measure [clinicaltrials_vocabulary:measure]
test the hypothesis that prepr ...... glargine with respect to HbA1c
time frame [clinicaltrials_vocabulary:time-frame]
12 weeks per therapy
description
Administer subcutaneous regula ...... als.
Inject into abdomen only.
identifier
clinicaltrials_resource:9413a3b5b9f427c08dc62172edf5d7fd
title
test the hypothesis that prepr ...... to HbA1c 12 weeks per therapy
@en
type
label
test the hypothesis that prepr ...... 3a3b5b9f427c08dc62172edf5d7fd]
@en